Garcia, Jacqueline S <br/><br/>
Prospects for Venetoclax in Myelodysplastic Syndromes.  [electronic resource] 

 -  Hematology/oncology clinics of North America  04 2020 
 - 441-448 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1558-1977 
<br/><br/><label>Standard No.: </label>10.1016/j.hoc.2019.10.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Clinical Studies as Topic<br/>Disease Management<br/>Disease Models, Animal<br/>Disease Susceptibility<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mitochondria--drug effects<br/>Myelodysplastic Syndromes--diagnosis<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Sulfonamides--pharmacology<br/>Treatment Outcome